期刊文献+

肺癌合并侵袭性肺曲霉病患者生存率及死亡危险因素分析 被引量:9

Survival rate and mortality risk factors in invasive pulmonary spergillosis patients with lung cancer
暂未订购
导出
摘要 目的 探讨肺癌合并侵袭性肺曲霉病(IPA)患者的生存率及死亡危险因素。方法 分析2010年1月~2013年12月在华西医院住院的108例肺癌合并侵袭性肺曲霉病患者的临床资料,随访患者后续治疗情况、死亡原因、死亡时间;并以确诊肺癌合并IPA后12周为随访终点,将患者分为死亡组和存活组,比较两组间临床特征的差异,寻求肺癌合并侵袭性肺曲霉病患者短期内死亡的危险因素。结果 至随访结束,肺癌合并侵袭性肺曲霉病患者共有67人死亡;单因素分析显示:年龄≥60岁(P=0.008)、Ⅳ期肺癌(P=0.004)、合并肺部其他感染(P=0.005)、合并器官衰竭(P=0.009)、粒缺≥Ⅲ级(P=0.032)、全身使用糖皮质激素(P=0.007)、低蛋白血症(P=0.005)、不进行抗曲霉治疗(P=0.028)是肺癌合并侵袭性肺曲霉病患者死亡的危险因素。结论 肺癌合并侵袭性肺曲霉病患者的全因死亡率为62.0%,1年(52周)生存率为39.6%,中位生存期为12周。年龄≥60岁、Ⅳ期肺癌、合并肺部其他感染、合并器官衰竭、粒缺≥Ⅲ级、全身使用糖皮质激素、低蛋白血症、不进行抗曲霉治疗是肺癌合并侵袭性肺曲霉病患者死亡的危险因素。 Objective This study explored the mortality risk factors and survival rate of aspergillosis in patients with lung cancer. Methods This study was the retrospective cohort study, which recruited 108 lung cancer patients with invasive pulmonary aspergillosis hospitalized in West China Hospital between January 1, 2010 and December 31, 2013. The clinical data were collected to understand the general situation, treatment process, treatment reaction of the patients, and patients were followed up for the outcome of treatment, cause and date of death. The clinical characteristics of lung cancer patients complicated with invasive pulmonary aspergillosis were statistical analyzed for the survival situation, risk factors, and prognostic factors. Results All-cause mortality of the lung cancer patients with invasive pulmonary aspergil- losis was 62%. 1 year (52 weeks) survival rate was 39.6%, and the median survival was 12 weeks. The age of 60 years or older (P=0. 008), stage IV lung cancer (P=0. 004), pulmonary infection (P=0. 005), the other organ failure (P= 0. 009), Class III or IV neutropenia (P=0. 032), systemic administration of corticosteroids (P=0. 007), hypoproteine- mia (P=0. 005), anti-fungal therapy absence (P=0. 028) were the main risks of death in lung cancer patients with inva- sive pulmonary aspergillosis. Conclusion All-cause mortality of the lung cancer patients with invasive pulmonary asper- gillosis was 62%. 1 year (52 weeks) survival rate was 39.6M, and the median survival was 12 weeks. The age of 60 years older, stage IV lung cancer, pulmonary infection, combined with the other organ failure, Class Ⅲ or IV neutrope- nia, systemic administration of corticosteroids, hypoproteinemia, antifungal therapy absence were the risk factors of death for lung cancer patients with invasive pulmonary aspergillosis.
出处 《西部医学》 2016年第1期45-48,共4页 Medical Journal of West China
基金 国家自然科学基金(81201851) 四川省科技厅科技支撑计划项目(2014SZ0231)
关键词 肺癌 侵袭性肺曲霉病 危险因素 生存率 Lung cancer Invasive pulmonary aspergillosis Risk factors Survival rate
  • 相关文献

参考文献22

  • 1Allemani C, Weir HK, Carreira H, etal. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25, 676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) [J~. Lancet, 2015,385 ( 9972 ) : 977- 1010.
  • 2王存德,刘坤,江波,黄晓霞,王瑜.恶性肿瘤患者并发医院真菌感染的临床分析[J].中华医院感染学杂志,2003,13(8):730-731. 被引量:30
  • 3杨艳荣,张志强,臧树志.肺癌患者肺部真菌感染临床分析[J].中华医院感染学杂志,2014,24(16):3988-3989. 被引量:13
  • 4Olobatoke AO, David D, Hafeez W,et al. Pulmonary carcino- sarcoma initially presenting as invasive aspergillosis: a case re- port of previously unreported combination ~J]. Diagn Pathol, 2010,5(11) :1746-1749.
  • 5Wu T, Li P, Wang M, Wang Q,et al. Pulmonary solid tumor with coexisting pulmonary aspergillosis~ Case reports and litera- ture review [J3. Clin Respir J, 2015,10(11) ..11-15.
  • 6Chen KY, KoSC, HsuebPR, et al. Pulmonary Fungal Infection Emphasison Microbiological Spectra, Patient Outcome, and Prog- nostic Factors [J~. Chest,2001,120(1) ~ 177-184.
  • 7Xi Yan,Mei Li, Ming Jiang, et al. Clinical Characteristics of 45 Patients With Invasive Pulmonary Aspergillosis: Retrospective Analysis o{ 1711 Lung Cancer Cases ~]]. Cancer,2009,115(21) : 5018-5025.
  • 8Ohmagari N, Raad II, Hachem R, et al. Invasive aspergillosis in pa- tients with solid tumors [J]. Cancer, 2004,101(10) :2300-2302.
  • 9Peghin M,Ruiz-Camps I, Garcia-Vidal C,etal. Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors [J]. J Infect, 2014,69(4) :387-395.
  • 10Steinbach WJ, Marr KA, Anaissie EJ, et al. Clinical epidemiol- ogy of 960 patients with invasive aspergillosis from the PATH Alliance registry EJ]. J Infect, 2012,65(5) ;453-464.

二级参考文献27

  • 1凌莉,毛剑秋,胡孟璇,郑受昂,郭媛卿,丘红.中山市1984一1988年鼻咽癌患者的预后分析[J].癌症,1994,13(2):123-127. 被引量:3
  • 2樊润玉 吴瑶.医院内真箧感染166例分析[J].中华医院感染学杂志,1999,6(3):138-138.
  • 3Dean D, Burchard KW. Fungal infection in surgical patients[J]. Am J Surg,1996,171:374.
  • 4Ehninger G, Schuler HK, Sarnow E. Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation[J].Mycoses, 1996,39 : 259.
  • 5方积乾,医学统计学与电脑实验,1997年,334页
  • 6Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61:69-90.
  • 7Hu Z, Wu C, Shi Y, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet, 2011, 43:792-796.
  • 8Dai J, Hu Z, Dong J, et al. Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese. Int J Cancer, 2012, 130:671-676.
  • 9Wu L, Chang W, Zhao J, et al. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer. Clin Cancer Res, 2010, 16:3760-3768.
  • 10blu R,Jiang X,Wu Y. Prospective trial finds nystatin mouth wash effective prophylaxis for pulmonary invasive fungalinfections that originate in the throat of patients with hemato- logic malignancies[J]. Neoplasma,2013,60(3) :315-321.

共引文献77

同被引文献49

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部